By transducing CTL clones with TCRs isolated from CD8+ T cells exhibiting strong effector/suppressor properties, it may be possible to develop more potent anti-viral CTLs for evaluation in the rhesus/SIV system with the potential to apply the same approach to HIV/AIDS. This evidence concerns the gene CD8A and AIDS.